ILUVIEN 190 micrograms intravitreal implant in applicator
Last Updated on eMC 06-Nov-2015 View document | Alimera Sciences Limited Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 06-Nov-2015 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
- Change to information for healthcare professionals
Updated on 29-May-2015 and displayed until 06-Nov-2015
Reasons for adding or updating:
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 18-Feb-2014 and displayed until 29-May-2015
Reasons for adding or updating:
- Change to section 6 - marketing authorisation holder
Updated on 14-May-2013 and displayed until 18-Feb-2014
Reasons for adding or updating:
- New PIL for new product
Alimera Sciences Limited
Royal Pavilion, Wellesley Road, Aldershot, Hamsphire, GU11 1PZ
+44 (0) 1252 354 012
+44 (0) 1252 354 000
0800 019 1253
0800 148 8274
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue